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Experiments with radiation-induced bone marrow chimeras and thymus-recon- 
stituted nude mice have shown that the repertoire of T  cells is influenced greatly 
by the major histocompatibility complex (MHC) 1 genes expressed in their devel- 
opmental  milieu.  For class I  MHC-restricted  T  cells,  there  appear to be both 
thymic and  extrathymic  influences  on  the  repertoire  (1-8),  while  for  class  II 
MHC-restricted T  cells, the I  region gene phenotype of the thymus appears to 
determine entirely the self-restriction specificity (9-13). The precise mechanism 
by  which  the  thymus  shapes  the  T  cell  receptor  repertoire  is  unclear,  but  it 
appears  that  bone  marrow-derived,  medullary,  Ia-bearing,  thymic,  antigen- 
presenting ceils (APC) play a critical role in determining class II MHC-restriction 
specificity (14-16). 2 
In  these experiments,  the process that generates  the  T  cell  repertoire  is not 
readily accessible to  experimental  manipulation.  The  recent  development of a 
model system in which mice are treated from birth with anti-I-A has allowed us 
to  look  at  the  process  of T  cell  development  more  closely.  In  addition  to  its 
effects on  B  cell development  (17),  chronic anti-I-A treatment  early in  life has 
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profound effects on T  cell development (18), 3 despite the fact that murine T 
cells  do not express  I-A.  Thymic and splenic Ia-antigen expression is strongly 
reduced in mice treated neonatally with anti-I-A (17,  18). In vitro cytotoxic T 
lymphocyte (CTL)  responses  to  alloantigens and  trinitrophenyl-modified-self 
antigens by spleen cells from such mice could only be generated in the presence 
of an exogenous source of interleukin 2 (IL-2) (18), implying that T  cells capable 
of generating  helper  factors in  vitro  are  defective  in  anti-I-A-treated  mice. 
Finally, recent  studies  3 demonstrated abrogation  of allo-class  II-specific and 
self-class II-restricted T  cell proliferative responses in both thymus and spleen 
of  anti-I-A-treated mice. These data (18) 3 suggested that class II MHC-restricted 
T  cells were either missing or functionally defective in mice treated from birth 
with anti-I-A. 
In an effort to distinguish whether class II-restricted T  cells  were absent or 
defective in this model, we examined the effects of neonatal anti-I-A treatment 
on the L3T4 and Lyt-2 surface phenotype of thymic and splenic T  cells, and on 
their class II-specific T  cell functions. In addition, we tested the hypothesis that 
the T  cell defects reported here and previously (18) ~ were somehow related to 
the reduced thymic Ia antigen expression (18)  by assessing the relationship of 
the class II-specific T  cell defects to the function of thymic APC. Identifying  the 
L3T4 and Lyt-2 phenotype of T  cells should be a reliable measure for presence 
or  absence  of a  particular  T  cell  subset  because  of the  striking  correlation 
between cell surface phenotype and MHC-subclass specificity. The expression of 
Lyt-2,3 molecules on mature mouse T  cells usually correlates with class I MHC 
specificity (19-23), while expression of the L3T4 antigen correlates with class II 
MHC specificity (24-29).  How this impressively strong association between T 
cell surface marker expression and MHC-subclass specificity is acquired in the 
developing  T  cell  repertoire  is  unknown.  In  the  thymus,  all  precursors  of 
alloreactive IL-2-producing T  cells are contained within the subset of phenotyp- 
ically "mature" Lyt-2-,L3T4  + T  cells (30),  while all alloreactive CTL precursors 
are recovered in the Lyt-2  + subset of "mature" T  cells (31). 
We report here that the functional defects in class II-restricted T  cells in anti- 
I-A-treated mice are  correlated with an absence  of the  Lyt-2-,L3T4  + T  cell 
subset, and with absence of functional thymic APC. The Lyt-2+,L3T4  -  class I- 
restricted T cell subset develops normally in these mice. When anti-I-A treatment 
is  stopped,  thymic and  splenic  APC  function return  to  normal, and  the  Lyt- 
2-,L3T4  +, class  II-restricted T  cell subset reappears, first in the thymus, with 
return of these cells to the periphery lagging behind. Collectively, these findings 
suggest that development of Lyt-2-,L3T4  +, class II-restricted T  cells is depend- 
ent on I-A-bearing thymic APC, and that the Lyt-2+,L3T4  -, class I-specific T 
cell subset develops by a distinct mechanism, unaffected by anti-I-A. 
Materials and Methods 
Mice and Anti-I-A Treatment.  Neonatal C57BL/6 (H-2 b) mice were treated within 24 h 
of birth with protein A-purified anti-I-A  b (hybridoma Y-3P [32], a kind gift from Dr. 
3  In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development  of 
the class I-, class II- and M  I  s-reactive proliferating  T cell subset, 1985. A. M. Kruisbeek,  S. Bridges, 
J. Carmen, D. L. Longo,  and J. J. Mond.  J. lmmunol. In press. KRUISBEEK ET  AL.  1031 
Charles A. Janeway, Yale University, New Haven, CT) and treated every 48 h thereafter. 
Intraperitoneal injections of 600,  800, and  1,000 #g of antibody were given during the 
first, second, and third week of life, respectively. Mouse strains to be used as donors for 
stimulator cells were DBA/2, B6.C.H-2  b~"l, D 1  .LP, B10.D2 (The Jackson Laboratory, Bar 
Harbor, ME) and B6.C.H-2  bm~2 (bred in our facilities from breeding pairs provided by 
Drs. Richard Hodes, NIH, and Ted Hansen, Washington University, St.  Louis, MO). H- 
2  and  Mls phenotypes of these strains are:  DBA/2:H-2 d,  Mlsa;  B10.D2:H-2 d,  Mlsb; 
B6.C.H-2bml:  H-2  b (K  bm~ mutant),  Mlsb; DI.LP:  H-2  b, Mlsa;  B6.C.  H-2bm12:H-2  b (I  b"~2 
mutant),  Mls  b.  Mice  treated  with  anti-I-A  were  killed  at  3  wk  of age,  either  after 
continuous antibody treatment, or after 1 wk of treatment and 2 wk with no treatment. 
Generation  of  T  Cell  Proliferative  Responses  in  Mixed  Lymphocyte Culture  (MLC). 
Responder thymocytes were cultured at 6  ×  105 cells/well, and spleen cells at 4  ×  l0 b 
cells/well, with varying concentrations (2, 4, and 8 ×  105) of 2,000 rad irradiated ailogeneic 
stimulator spleen cells in a  final  volume of 0.2  ml of complete tissue  culture  medium 
consisting of half RPM I 1640, half Eagle's Hanks' amino acids medium (33) supplemented 
with 10% fetal calf serum (HyClone Laboratories, Logan, UT), 2 mM glutamine, penicillin 
(100  U/ml),  streptomycin (100  mg/ml),  2-mercaptoethanol (5  ×  10  -~ M),  and sodium 
pyruvate (0.11  mg/ml). This medium is referred to as E/R. Triplicate cultures were set 
up in round-bottom (thymocytes) or flat-bottom (spleen cells)  96-well microtiter plates. 
On day 4  for thymocytes or day 3  for spleen cells,  1 t~Ci of [SH]thymidine (sp act 6.7 
Ci/mmol; New  England  Nuclear,  Boston,  MA)  was added per well,  and cultures  were 
harvested 16-18 h later on an automated sample harvester. ['H]Thymidine incorporation 
was measured in a  liquid scintillation counter, and data are expressed as the arithmetic 
mean cpm. SEM were <20%. 
Fluorescence Staining  and  Two-color Fluorescence-activated Cell  Sorter  (FACS) Analy- 
sis.  Spleen cell and thymocyte suspensions from normal and anti-I-A-treated mice were 
prepared in Hank's balanced salt solution (without phenol red) containing 0.1%  bovine 
serum albumin (BSA) and 0.1% sodium azide (FACS buffer). Cells (106]30 #i buffer) were 
incubated on ice for 30 min with 10 #l of the appropriate reagent, and washed twice after 
each incubation. For two-color FACS analysis of L3T4 and Lyt-2, the following sequence 
was  used  for  thymocytes:  (a)  anti-Lyt-2.2  culture  supernatants  (mouse  IgG2a,  clone 
19/178 [34]); (b) Texas Red (TR)-Iabeled, affinity-purified goat anti-mouse Ig (crossreac- 
tive with rat Ig) (35); (c) normal mouse serum (NMS); (d) anti-L3T4 culture supernatant 
(rat IgG2b, clone GK-1.5 [24, 27]); (e) fluorescein isothiocyanate (FITC)-conjugated goat 
anti-rat IgG (not crossreactive with mouse IgG) (Cappel Laboratories, Cochranville, PA). 
The sequence  used  for spleen  cells was (a) anti-L3T4  culture  supernatant;  (b)  FITC- 
conjugated  mouse  anti-rat  g  (mouse  IgG2a,  clone  Marl8.5  [36]);  (c)  rat  lg  fraction 
(purified  from  rat  serum);  (d)  biotin-labeled  anti-Lyt-2  (rat  IgG2a,  clone  53-6.7  [37] 
purified by ion-exchange and gel filtration); or (e) TR-avidin. NMS or rat Ig, which had 
the capacity to react with both primary antibodies, was used to block unoccupied binding 
sites on bound second antibody.  Control cells,  either  unstained or stained with second 
antibody alone, were used to obtain background fluorescence levels.  In later experiments, 
not shown here, we used, with equal success, the following sequence for both thymocytes 
and spleen cells:  (a) biotin-labeled anti-L3T4; (b) TR-avidin; (c) FITC-conjugated anti- 
Lyt-2. 
Flow microfluorometry analysis was performed on a  FACS II (Becton-Dickinson and 
Co., Mountain View, CA), and analyzed by a PDP  11/34 computer (Digital Equipment, 
Marlboro, MA), using programs previously described (38).  All data were collected using 
log amplifiers and  displayed on a  log~0 scale of increasing green and red  fluorescence 
intensity, without defining units.  Subpopulations in stained samples that did not differ 
from the unstained control were scored as negative. Dead cells were rejected from analysis 
by forward light scatter (39) and propidium iodide staining (PI) by electronic gating.  10 
#1 of PI at 50 mg/ml in 0.1% sodium citrate (40) were added to the cell sample just prior 
to FACS-analysis. 
Generation of IL-2  in  Limiting-dilution  Microculture.  A  modification  of the  method 
described  by  Miller  and  Stutman  (41)  was  used.  Responder  C57BL/6  spleen  cells  or 1032  ABSENCE  OF  Lyt-2-,L3T4  + CELLS  IN  ANTI-I-A-TREATED MICE 
thymocytes were, in  some experiments, depleted  of Lyt-2-bearing cells  by anti-Lyt-2.2 
monoclonal antibodies (mAb) and complement treatment to eliminate cells that may use 
IL-2 (42). Stimulator cells were nonirradiated resident peritoneal cells from C57BL/10 X 
B10.D2 F~ nude mice or C57BL/6 X bml2 F~ mice treated wtih anti-Thy-l.2 mAb plus 
complement to eliminate T  cells; these stimulator cells were shown to be devoid of T cells 
by their inability to generate a concanavalin A-induced proliferative response (data not 
shown). Varying numbers of untreated or Lyt-2-depleted responder cells were cultured 
in round-bottom wells of 96-well microtiter plates with  1-5 ×  104 Fl stimulator cells for 
5 d. After centrifugation of the plates at 500 g, 100 #i of supernatant was removed from 
each well,  and tested for its IL-2 activity by measuring its ability to support growth of 
CTLL cells (an IL-2-dependent CTL line).  The supernatants to be tested were cultured 
with  2  ×  103 CTLL cells  in fiat-bottom wells  of 96-well microtiter plates.  After 24  h, 
cultures were labeled with 1/~Ci of [SH]thymidine for 4-6 h, and harvested and processed 
as "described above for MLC  cultures.  Supernatants  of microcultures were  defined  as 
positive when the IL-2 activity exceeded by >3 SD the mean [3H]thymidine incorporation 
of CTLL cells grown in control supernatants (i.e., obtained from 5-d cultures of stimulator 
cells only). Minimal estimates of the precursor frequencies were calculated by plotting the 
percent negative cultures against cell dose, according to the Poisson model, and by using 
the minimum X  2 method of estimating the frequency, as described by Taswell (43). 
Measurement  of APC Function for  l-region-spec~c  T  Cells with Antigen-reactive  T  Cell 
Clones.  Antigen-reactive T  cell clones were derived from draining lymph nodes of mice 
immunized  with  keyhole limpet  hemocyanin (KLH) (lot  230145,  Calbiochem-Behring 
Corp., San Diego, CA) 8-10 d earlier (50 #g KLH per hind foot pad in an emulsion with 
complete Freund's adjuvant) as previously described (44). The cells were cloned by limiting 
dilution  2 d after the third stimulation with antigen and syngeneic 3,300 rad irradiated 
spleen cells. Alloreactive T  cell clones were derived from secondary MLC; both antigen- 
specific and  alloreactive T  cell  clones  were  maintained  by alternating  4-d  periods  of 
stimulation and 7-d periods of rest with syngeneic irradiated spleen cells.  I-region speci- 
ficity was determined by mapping using recombinant mouse strains, and by inhibition of 
proliferation with  mAb of the  appropriate  specificity. All  clones were independent  of 
exogenous IL-2 for their proliferation. 
T  cell clones recovered at the end of the rest period were used to assay APC function 
of thymocytes or spleen cells from control or anti-I-A-treated mice.  10  ~ cloned T  cells 
were cocultured with various doses of 2,000 rad irradiated APC and, when appropriate, 
KLH, in a  final volume of 0.2  ml of E/R in flat-bottom, 96-well microtiter plates. [3H] 
Thymidine incorporation was assessed on day 2 or 3 as described above for MLC. APC 
were light-density cells collected from a discontinuous BSA gradient consisting of a 35% 
and an  11%  layer, spun at 25,000 g. Cells from the interface between the layers were 
washed twice in E/R without FCS. This enrichment for light-density cells is specifically 
necessary to measure thymic APC function (14). 
Results 
Lyt-2-,L3T4 + T  Cells Are Not Present in Spleen or Thymus from Anti-I-A-treated 
Mice.  The  key  question  to  be  addressed  regarding  the  defects  in  anti-I-A- 
treated mice is whether the absence of T  cell functions generally associated with 
class lI recognition (18) 3 is due to the absence of a  subpopulation of T  cells, or 
to  functional  defects  in  the  subpopulation  of T  cells  responsible  for  class  II 
recognition. This question  may be answered by analyzing expression of the cell 
surface  markers  associated  with  T  cells'  specificity for the  class  I  and  class  II 
MHC subregions.  Expression of the L3T4 marker correlates with specificity for 
class II-MHC gene products (23-27). Lyt-2 expression, on the other hand, usually 
correlates  with  T  cell  specificity  for  class  I-MHC gene  products  (21-23).  We 
studied  expression  of  the  L3T4  and  the  Lyt-2  antigens  on  spleen  cells  and KRUISBEEK  ET  AL.  1033 
thymocytes from 3-wk-old anti-I-A-treated mice, using two-color flow cytometric 
analysis. The results obtained with spleen cells using GK-1.5 (recognizing LBT4) 
and anti-Lyt-2 (Fig.  l) show, in both adult and 3-wk-oid normal spleen cells (Fig. 
1, top and bottom), distinct populations of Lyt-2-,L3T4 + cells, and Lyt-2+,L3T4 - 
cells.  In contrast,  the subset of Lyt-2-,L3T4 + cells is entirely absent in spleen 
cells  from  3-wk-old anti-I-A-treated  mice (Fig.  1,  middle).  In a  series  of five 
experiments, 6.2 _+ 0.05% (mean +SE) of normal spleen cells expressed the Lyt- 
2-,LBT4 + phenotype, while in spleen cells from anti-I-A-treated mice, only 0.9 
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FIGURE  1.  Two-color  FAGS  analysis of  Lyt-2  (red  fluorescence,  ordinate) and  L3T4 
(green fluorescence, abscissa) on spleen cells from control (top) and anti-I-Ab-treated (middle) 
C57BL/6  mice.  Spleen  cells  from  2-3  control  or  anti-I-A-treated mice  were  pooled  and 
stained, first with FITC-anti-L3T4,  then washed and stained with biotin-labeled anti-Lyt-2, 
followed by Texas Red-avidin. For comparison, a similar analysis of adult (10-wk-old) spleen 
cells is given (bottom). IL-2 production by spleen cells from these same mice is shown in Fig. 3. 1034  ABSENCE  OF  Lyt-2-,L3T4 + CELLS IN  ANTI-l-A-TREATED MICE 
+  0.2%  Lyt-2-,L3T4  + cells were found. This suggests that the absence of allo- 
class II-specific and self-class II-restricted proliferative responses in spleen cells 
from anti-I-A-treated mice  ~ is due to absence of the Lyt-2-,L3T4  + T  cell subset 
responsible for these functions, rather than functional defects in such cells. 
Since thymocytes from anti-I-A treated mice also exhibit inability to generate 
allo-class  II-specific  and  self-class  II-restricted  proliferative  responses,  3 it  is 
likely that  anti-I-A  affects intrathymic  T  cell development as  well.  Two-color 
flow cytometry analysis of thymocytes supports tbis notion.  In both adult  (Fig. 
2, bottom)  and 3-wk-old normal thymocytes (Fig. 2, top),  four subpopulations are 
detected  after  staining  for  L3T4  and  Lyt-2:Lyt-2+,L3T4  +  (representing  the 
cortical type, immature T  cells [30, 31 ]), Lyt-2+,L3T4  -  (representing functional 
CTL precursors [31 ]); Lyt-2-,L3T4  + (representing functional class II-restricted 
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C57BL/6 mice. Legend as in Fig. 1.1L-2 production by thymocytes from these same mice is 
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IL-2-producing cells [30, 31]); and Lyt-2-,L3T4-, a small subpopulation includ- 
ing the dull Lyt-1 +,Lyt-2- (dLy 1) precursor thymocyte (45). A striking difference 
emerged when thymocytes from 3-wk-old anti-I-A-treated mice were tested: the 
subpopulation  of Lyt-2-,  L3T4 + T  cells is  completely absent  (Fig.  2,  middle), 
with no apparent change in the other subpopu|ations. In a series of five experi- 
ments, 9.8 +  0.01% Lyt-2-,L3T4  + cells are detected in normal thymus, while in 
anti-I-A-treated  mice, only 1.7 +  0.02% of these cells was present. Thus, anti-I- 
A treatment selectively affected development of the Lyt-2-,L3T4  + T  cell subset. 
Previous publications (23-27,  30) ascribed both antigen  plus class II  MHC- 
restricted  or class  II-alioantigen-specific  proliferation  and  IL-2  production  to 
Lyt-2-,L3T4  + cells.  We therefore wished to determine whether the absence of 
the  Lyt-2-,L3T4  + T  cell subset in  anti-I-A-treated  mice  was accompanied  by 
lack of IL-2 production.  Alternatively, anti-I-A treatment could have led to loss 
of the L3T4 marker,  without loss of functions associated with this subset. Using 
a  microculture  system developed by others (41),  IL-2 production  in individual 
microcu]tures of normal and anti-I-A-treated  spleen cells in response to stimu- 
lation by semiallogeneic stimulator cells was determined. Under such circumstan- 
ces,  most  of the  IL-2  produced  is  released  by  Lyt-2-  cells,  which  respond 
preferentially to class II differences (30, 41, 42). Responder cells were pretreated 
with anti-Lyt-2 plus complement to remove cells that do not produce, but may 
use IL-2 (42).  Recovery of spleen cells after such treatment  was 70-80%  from 
both  normal  and  anti-I-A-treated  spleen  cells.  As  shown  in  Fig.  3,  when  the 
supernatants  from  individual  microcultures  were  tested  for  IL-2,  spleen  cells 
from  anti-I-A-treated  mice  exhibited  an  obvious decrease  in  the  number  of 
positive cultures. The frequency of IL-2-producing cells under these conditions 
was 1/189 for normal spleen cells, compared with  1/5,810 for spleen cells from 
anti-I-A-treated  mice (mean of 10 separate experiments; see also Table I). The 
normal spleen cell values are within the range of those previously reported (4 I, 
42,  46)  for  adult  spleen  cells.  Similar  results,  i.e.,  a  strong  decrease  in  the 
frequency of IL-2-producing precursors in anti-I-A-treated mice, were observed 
when  responder  cells were not depleted  of Lyt-2  ÷ cells (data  not shown).  We 
choose  to  present  data  with  Lyt-2-  responder  cells only,  because under  such 
circumstances  more accurate frequency determinations  are obtained (42), pre- 
sumably because Lyt-2  + cells may use IL-2. 
A  similar analysis with thymocytes was found to be technically difficult: after 
treatment of normal thymocytes with anti-Lyt-2 plus complement, 6-10% of the 
cells could  be  recovered,  while,  with  tbymocytes from  anti-I-A-treated  mice, 
often only very few cells survived the treatment. Nonetheless, data representative 
of four  interpretable  experiments  with  Lyt-2-  thymocytes are  presented.  A 
limiting-dilution  analysis of the Lyt-2- thymocyte population of normal and anti- 
I-A-treated mice indicated (Fig. 4) that virtually no microcultures in the anti-I- 
A-treated group released detectable levels of IL-2; in three out of four experi- 
ments, a frequency of<l/104 was found (see also Table I). In contrast, even low 
numbers of normal thymocytes are, as reported earlier (30, 31), able to give rise 
to easily measurable levels of IL-2: for four experiments, an average frequency 
of 1/286 (see also Table I) of IL-2-producing precursors was observed. Compa- 
rable  results  were  obtained  with  untreated  responder  thymocytes  (data  not 1036  ABSENCE  OF  Lyt-2-,L3T4 +  CELLS  IN  ANTI-I-A-TREATED  MICE 
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mean of control wells receiving no responder cells (solid line) by more than three SD of the 
mean (broken line). For frequency values, see Table I. 
shown). Taken together, these data demonstrate that in vivo anti-I-A treatment 
results in a T  cell function defect strictly confined to the Lyt-2-,L3T4 + subset. 
Such  cells are  markedly  decreased  in  either thymus  or  spleen  from anti-I-A- 
treated  mice,  and  functions  associated  with  this  subset,  i.e.,  class  II-MHC- 
restricted T  cell proliferation  3 and IL-2 production are strongly diminished, or 
absent. 
Correlation  of Defective  Proliferative  T  Cell Response with Defective  Thymic APC 
Function in Anti-I-A-treated Mice.  It was previously observed (18) that Ia antigen 
expression in thymuses from anti-I-A-treated  mice was strongly diminished.  It 
has also been shown (14,  15)  2 that one pathway of acquisition of T  cell I-region 
recognition is through  interaction  in the thymus with a bone marrow-derived 
cell that functions as an APC. In view of the absence of class II-restricted T  cell 
responses  3 and lack of the Lyt-2-,L3T4 + subset in anti-I-A-treated  mice, it was 
of interest  to  analyze  their  thymic  APC  function.  Splenic  APC  function  was 
probed  as  well,  because  splenic  Ia  antigen  expression  is  completely  absent  in KRUISBEEK ET  AL. 
TABLE  I 
Frequency of lL-2-producing  Cells among Lyt-2- Thymocytes and Spleen 
Cells from Control and Anti-I-A-treated Mice 
1037 
Frequency of 
T cell-depleted  stimu-  IL-2-producing  Exp.  Lyt-2- responder cells  lator cells 
cells* 
1'  Control spleen  B10 × B10.D2 F1  1/400 
Anti-I-A spleen  1/2,808 
Control thymus  1/356 
Anti-I-A thymus  1/9,535 
2  Control spleen  1/89 
Anti-I-A spleen  1/3,081 
Control thymus  1/280 
Anti-I-A thymus  < 1  / 104 
3  Control spleen  1  / 112 
Anti-I-A spleen  1/8,486 
Control thymus  1/153 
Anti-I-A thymus  < 1  / 104 
48  Control spleen  B6 × bml2 F~  1/110 
Anti-I-A spleen  1/4,100 
Control thymus  1/349 
Anti-I-A thymus  <1/104 
* In all experiments a linear semilogarithmic relationship between the proportion 
of negative cultures and the dose of responder cells was observed. 
* Experiment also shown in Figs. 3 and 4. 
An experiment with an only allo-I-region difference was included to illustrate 
that most IL-2 production  under the circumstances used is a reflection of I- 
region recognition. 
these mice (17). The results in Fig. 5 show that spleen cells and thymic ceils from 
anti-I-Ab-treated B6 (H-2 b) mice were defective in presenting  KLH to an  I-A  b 
plus KLH-specific T  cell clone. Similar results were obtained with two other  I- 
A b plus  KLH-specific  T  cell  clones,  and  with  two  ailoantigen-specific  T  cell 
clones that recognize I-A  b antigens (data not shown).  This strongly argues that 
anti-I-A-treated  mice lack  functional  Ia-bearing APC  in both  the  thymus and 
the spleen. The failure of cells from anti-I-A-treated mice to induce proliferation 
in several different clones suggest that the APC lack I-A, rather than expressing 
altered  I-A molecules.  Mixing experiments,  using APC  from both  normal and 
anti-I-A-treated mice, excluded induction of suppressor cells as the cause for the 
abrogation  of APC  function  in  anti-I-A-treated  mice  (data  not  shown). 4 The 
possible contribution  of defective  thymic and/or  splenic  APC  function  to  the 
observed  defect  in  class  II-restricted  T  cell  proliferative  responses  was  also 
studied.  B6 mice were treated for  1 wk with anti-LA  b, then left untreated for 2 
wk,  and  subsequently  tested  for  their  ability  to  generate  thymic  and  splenic 
proliferative responses  in  MLC.  Fig.  6  shows a  typical pattern  of the  effect of 
this treatment schedule. While splenic responses are still considerably suppressed 
in such mice, and,  in fact, indistinguishable  from mice treated continuously for 
4 In vivo treatment  of adult  mice with anti-I-A antibodies:  Disappearance of splenic antigen 
presenting cell function concommitant with modulation of splenic cell surface I-A and I-E antigens. 
1985. A. M. Kruisbeek, J. A. Titus,  D. A. Stephany, B. L. Gause, and D. L. Longo. J. Iramunol. In 
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FIGURE 4.  Limiting-dilution analysis of IL-2  production by thymocytes from control and 
anti-I-Ab-treated C57BL/6  mice, Conditions as described in  legend to  Fig.  3,  except that 
thymocytes instead of spleen cells were used as responder cells. 
3  wk with anti-I-A, 3 after 2  wk of recovery, thymocyte proliferative responses 
had returned to almost normal values. Note that 1 wk of treatment is sufficient 
to suppress  both  thymocyte and splenic  MLC responses  (data  not shown).  In 
addition, the number of Lyt-2-,L3T4  + T  cells in the thymus returned to normal 
values 2  wk after anti-I-A treatment was terminated (data not shown). Thymic 
and splenic  APC  function were also tested  2  wk after termination of anti-I-A 
treatment. As shown in Fig. 7, thymic and splenic APC function from these mice 
is indistinguishable from that of untreated mice, even at low APC numbers. The 
mice used for the experiment in  Fig.  7  are the same as those used for Fig. 6. 
Thus,  an  interesting picture  emerges:  when  thymic APC  function is  reduced 
(Fig. 5), i.e., after 3 wk of continuous anti-Ia treatment, splenic and thymic class 
II-specific MLC responses, 3 as well as IL-2 production in response to an alloge- 
neic stimulus (Figs.  3  and  4)  are  reduced,  and  Lyt-2-,L3T4  + cells are  absent 
(Figs. 1 and 2.) However, when thymic APC function has become normal (i.e., 2 
wk after treatment has been stopped), thymic MLC responses (Fig. 6) and Lyt- 
2-,L3T4 +  cell  numbers  are  returning  to  normal  values,  while  splenic  MLC 
responses are  still diminished (Fig.  6).  Return  of splenic  APC  function is not 
correlated with return of splenic T  cell responses. We interpret these findings as 
indicating  that  the  generation  of  the  T  cell  subset  responsible  for  class  II KRUISBEEK  ET  AL. 
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FIGURE 5.  Splenic and thymic APC from B6 mice treated from birth with anti-I-A  b cannot 
present antigen (KLH) to KLH plus I-Ab-specific T  cell clones.  104 cloned T  cells from a 
KLH plus l-Ab-specific clone were cultured with the indicated doses of KLH, and either 2 x 
l0  s or 5  x  104 2,000 rad irradiated APC, collected from the interphase of a  BSA gradient 
consisting of a  35% and an  11%  BSA layer. Cultures were labeled with 1 /~Ci [SH]thymidine 
on day 2, and harvested on day 3.  [SH]Thymidine incorporation is expressed as the mean of 
triplicate cultures; standard deviation values were <14%. Control cpm values were 536 _+ 67 
for T cells alone, and ranged from 560 to 869 cpm for the various types and numbers of APC. 
recognition depends on thymic, rather than splenic APC function, and that after 
anti-Ia treatment, new T  cells capable of Ia recognition must be generated in 
the thymus before such cells can be detected in the periphery. 
Discussion 
Although the MHC  phenotype of the nonlymphoid cells in  the thymus has 
been implicated in the process that selects the MHC restriction specificities of T 
cells during  development (1-15),  the  precise intrathymic events determining 
acquisition of MHC restriction specificities remain unresolved. Some of the most 
basic questions regarding the development of class I- and class II-specific T  cells 
are: With which MHC-bearing nonlymphoid cells do developing T cells interact? 
Do cells destined to  become class  II-specific T  cells interact with intrathymic 
elements different than  those required for development of precursors of the 
class  I-specific repertoire? Do intrathymic events determine the strong associa- 
tion  between  expression  of L3T4  or  Lyt-2  and,  respectively,  MHC  subclass 
specificity for class II or class I? In the experiments reported here, an attempt is 
made to better understand development of MHC restriction specificities through 
interference  with  intrathymic  expression  of  MHC  antigens,  specifically  I-A 
antigens.  This  paper  also  describes  the  first  experiments  to  have  examined 
whether development of Lyt-2-,L3T4  + T  cells can be separated from develop- 
ment of the Lyt-2+,L3T4  - T  cell subset. 
We present evidence that, in mice treated from birth with anti-I-A, the thymus 
and spleen do not contain Lyt-2-,L3T4  + T  cells, as defned by dual-parameter 
FACS analysis.  We also investigated whether absence of Lyt2-,L3T4 ÷ T  cells 
was accompanied by decreased IL-2 production, and found that anti-I-A-treated 
mice develop  only very low  levels  of IL-2-producing  precursors.  Therefore, 
absence of the  Lyt-2-,L3T4  ÷ subset  of T  cells was  defined both  by  marker 1040  ABSENCE  OF  Lyt-2-,L3T4  ÷ 
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FIGURE 6.  Thymocyte proliferative responses to allogeneic stimulator cells recover be- 
fore spleen cell responses in B6 mice treated neonatally  with anti-l-A b, after the treatment is 
stopped.  4  ×  105  spleen  cells or 6  x  105  thymocytes  from control and  anti-I-A-treated 
C57BL/6 mice were cultured with the indicated  numbers of 2,000 tad irradiated allogeneic 
spleen cells, in a volume of 0.2 ml. Mice were either treated for 1 wk with anti-I-A b, then left 
untreated for 2 wk before being tested (O), or treated continuously  for 3 wk (Z~). 1 wk after 
treatment was terminated, thymocyte and spleen cell responses of mice from the same litter 
were still completely suppressed  (data not shown). Spleen cell cultures  were harvested  on day 
4; thymocyte cultures  were harvested on day 5, each after a  16-20 h labeling period in the 
presence of 1 #Ci of [SH]thymidine. Control values in cultures containing stimulator  cells only 
hml  varied from 700 to 1,400 cpm. Responses to a class I alloantigen difference (H-2  stimulator 
cells) or to Mls-disparate  stimulator  cells (D1.LP)  behaved similarly, spleen  cells being still 
almost entirely suppressed, and thymocytes exhibiting considerable recovery (data not shown). 
analysis and by function.  The presence of the lineage of Lyt-2+,L3T4 -  cells was 
similarly defined both functionally (i.e.,  normal CTL precursors were present in 
these mice) (18), and through marker analysis: the dual-parameter FACS patterns 
demonstrate  that the  number  of Lyt-2+,L3T4 -  T  cells in thymus and spleen  is 
not affected by neonatal anti-I-A treatment. 
Several points can be made regarding these findings.  First,  completion of the 
generation of the two major compartments of the T  cell repertoire  is clearly not 
a  single  event:  development  of  the  Lyt-2-,L3T4 +  lineage  can  be  selectively 
abrogated  by a  manipulation  (i.e.,  neonatal  anti-I-A  treatment)  that  leaves  the 
Lyt-2+,L3T4 -  lineage  unaffected.  Our  experiments  do not distinguish  whether 
the  Lyt-2-,L3T4 + subset  does  not develop at all,  or does develop,  initially,  but 
fails to expand to detectable levels.  Perhaps it needs interaction with intrathymic 
I-A-bearing  cells  (see  below)  or  factors  produced  by  such  cells  as  a  signal  to 
expand. KRUISBEEK  ET  AL.  1041 
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FIGURE 7.  In  B6  mice treated for 1 wk after birth with anti-I-A  b, APC function in spleen 
and thymus has returned to normal values 2 wk after the treatment is terminated. Conditions 
were as described in legend to Fig. 5. Thymus and spleen cell suspensions were from the same 
mice whose T  cell proliferative responses are shown in Fig. 6. Control cpm values were 468 _+ 
71  for cloned T  cells alone, and varied from 289 to 761  for the various types and numbers of 
APC. 
Second,  expression  of the  L3T4 + marker  is,  in  and  of itself,  not a  feature 
dependent on  intrathymic  I-A-bearing cells,  because normal  levels (~80%) of 
cells staining positively for both L3T4 and Lyt-2 are found in the thymus of anti- 
I-A-treated mice, in accord with previous reports on the size of this "immature," 
cortical thymocyte population (30) in the normal thymus. There is currently no 
consensus on the relationship  between the immature  Lyt-2+,L3T4  + subset and 
the lineages of Lyt-2+,L3T4 - and Lyt-2-,L3T4  + cells (45, 47-49); it is not clear 
whether precursors for either one or both of these lineages are contained within 
the  Lyt-2+,L3T4  + subset.  Several studies (45,  49,  50) identified a  dull  Lyt-1 +, 
Lyt-2-,L3T4- precursor cell of the  Lyt-2+,L3T4 + subset, while recent  5 in vivo 
transfer studies demonstrated that this Lyt-1 + dull precursor cell can give rise to 
all  three  other  thymocyte  subsets:  Lyt-2+,L3T4+;  Lyt-2-,L3T4+;  and  Lyt- 
2+,L3T4 -. Our findings suggest that generation of the subsets of Lyt-2+,L3T4  + 
and  Lyt-2+,L3T4 -  cells is not dependent on  I-A-bearing  elements affected by 
anti-I-A treatment, while generation of the Lyt-2-,L3T4  + subset is. Models such 
as this one may aid in further dissecting the intrathymic differentiation pathways 
leading to the various T  cell subsets. 
Third, the question arises whether, in fact, all IL-2-producing T  cells, regard- 
less of their  MHC subregion  specificity, are affected by anti-I-A  treatment.  In 
our experiments, IL-2 production was induced by a full MHC difference or class 
II-alloantigen  difference  only,  thus  reflecting  mainly  activation  of class  II- 
specific  Lyt-2- T  cells,  regardless  of whether  Lyt-2  + T  cells were present  or 
absent in the responder cell population (30, 41, 42). Accordingly, no conclusion 
can be made about the capacity of Lyt-2  + T  cells to produce IL-2. Although the 
Lyt-2  + subset, as defined by marker analysis, is apparently unaffected by anti-I- 
A  treatment,  additional  experiments  are  required  to  determine  whether  the 
5 Early T  lymphocytes: Differentiation in vivo of adult intrathymic precursor cells. B.J. Fowlkes, 
L. Edison, B.J. Mathieson, and T. M. Chused. Manuscript submitted for publication. 1042  ABSENCE  OF  Lyt-2-,L3T4 ÷  CELLS  IN  ANTI-I-A-TREATED  MICE 
frequency of IL-2-producing Lyt-2  + cells is affected. To  this end, stimulation 
with a class I-alloantigen difference only will be used (22, 23). 
The absence of the lineage of Lyt-2-,L3T4  ÷ T  cells in the present model was 
correlated with absence of thymic APC  function for class  II-specific T  cells. 
Thymic APC are bone marrow-derived (14,  16), and located in the medulla or 
at  the  cortico-medullary junction  (16,  51).  Most  of the  phenotypically and 
functionally "mature" thymocytes are located in the medulla (30, 31, 47, 52, 53). 
Taken together, these studies suggest that generation and/or expansion of the 
Lyt-2-,L3T4  + subset requires an interaction of an unknown thymocyte  precursor 
cell with I-A-bearing elements, presumably APC, in the thymus medulla. Addi- 
tional experiments are required to determine whether this interaction requires 
self-I-A recognition, as might be expected on the basis of experiments by others 
(54). Furthermore, thymic APC may have a nonspecific role in the expansion of 
thymocytes through release of factors such as IL-1. Finally, the question whether 
thymic APC have truly disappeared in anti-I-A-treated mice, or become non- 
functional  through  loss  of Ia-antigens  is  currently investigated  histologically, 
using a panel of mAb with which cortical and medullary thymic stromal cells can 
be distinguished on tissue sections (55). 
Notwithstanding the correlation between lack of thymic APC and absence of 
the Lyt-2-,L3T4  + subset, a contribution of the lack of B cells in anti-I-A-treated 
mice (17) to the peripheral T  cell defects may also be considered. Mice treated 
neonatally with anti-IgM (56-58) express altered Ig idiotype specificities in their 
T  cell  repertoire,  in  addition  to  lacking B  cells.  This  suggests  that  idiotype- 
specific interactions between B cells and T  cells contribute to the selection of T 
cell  repertoire  specificities.  Such effects might also  occur in  anti-I-A-treated 
mice. Some differences between anti-IgM- and anti-I-A-treated mice, however, 
should be mentioned: (a) antigen-specific helper T  cells are easily generated in 
anti-IgM-treated mice (57, 58), while anti-I-A-treated mice lack T  cells of the 
phenotype commonly associated with helper cell function; (b) although anti-IgM- 
treated mice have impaired antigen-specific T  cell proliferative responses, they 
express normal MLC reactivity (59), contrasting with the strongly impaired MLC 
reactivity in  anti-I-A-treated mice  s (this report).  It  remains to  be established 
whether the absence of the B cell compartment in anti-I-A-treated mice affects 
the T  cell repertoire. We propose that a primary defect is an inability of the Lyt- 
2-,L3T4 + subset to develop or expand intrathymically in the absence of func- 
tional I-A-bearing APC. 
Summary 
In an effort to elucidate the role of intrathymic Ia-bearing antigen-presenting 
cells (APC) on the development of the class  II-restricted T  cell repertoire, we 
examined the effect of neonatal  anti-I-A treatment on  both  intrathymic and 
splenic APC function; on the generation of Lyt-2-,L3T4  +, Lyt-2+,L3T4  -, and 
Lyt-2+,L3T4  ÷ T  cells;  and on the development of class I- and class  II-specific 
T  cell functions. Both the thymus and the spleen are completely devoid of Lyt- 
2-,L3T4 + T  cells in young mice treated from birth with anti-I-A, and also lack 
functions associated with this subset, i.e., alloantigen-specific interleukin 2 pro- 
duction (present report), allo-class II-specific and self-class II-restricted T  cell KRUISBEEK ET  AL.  1043 
proliferative responses,  3 and helper cell function for the generation of cytotoxic 
T  lymphocyte responses (18). Development of the Lyt-2  +,L3T4- subset proceeds 
undisturbed in these mice, in accord with the previously reported normal levels 
of cytotoxic T  lymphocyte precursors (18). The thymus contains normal numbers 
of the immature cortical Lyt-2+,L3T4  + cells, indicating that acquisition of the 
L3T4  marker,  in and of itself, is  not  influenced by anti-I-A treatment. This 
striking absence of the lineage of T  cells responsible for class II-specific T  cell 
functions is correlated with absence of thymic APC function for class II-restricted 
T  cell  clones.  When  anti-I-A-treated mice  are  allowed to  recover  from  the 
antibody treatment, splenic and thymic APC function return to normal in 2-3 
wk, and  thymic Lyt-2-,L3T4  ÷ T  cell  numbers and functions reappear before 
such cells are detectable in the spleen. Collectively, these findings suggest that 
development of the Lyt-2-,L3T4  + lineage of class II-specific T  cells is entirely 
dependent on functional I-A-bearing APC cells in the thymus. In addition, the 
presence of normal levels of Lyt-2+,L3T4  - T  cells argues that generation of the 
two  major  subsets  of T  cells  (i.e.,  Lyt-2+,L3T4  -  and  Lyt-2-,L3T4  +)  occurs 
through separate events, involving unique sites of interactions between precursor 
T cells and nonlymphoid major histocompatibility  complex-bearing thymus cells. 
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